Achim Heinecke - Concepedia

Author

Achim Heinecke

Also Known As

A HEINECKE, A Heinecke, A. HEINECKE, A. Heinecke, ACHIM HEINECKE, Achim Heinecke, C. Sauerland, Cristina Sauerland, E. Thiel, Heinecke A.

282

Publications

15.7K

Citations

H-Index

123

Concepts

All Affiliations

University of Münster University Hospital Münster Heidelberg University Ludwig-Maximilians-Universität München Bundeswehr

About

Achim Heinecke is an author at University of Münster specializing in medicine, oncology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	45	3.1K
2	Health Sciences	13	16	1.1K
3	Engineering	2	2	63
4	Education	1	1	28
5	Language Studies	1	1	54

Achim Heinecke

128

Publications

13.1K

Citations

H-Index

Page 1

	Year	Citations
Primary Gastrointestinal Non-Hodgkin’s Lymphoma: I. Anatomic and Histologic Distribution, Clinical Features, and Survival Data of 371 Patients Registered in the German Multicenter Study GIT NHL 01/92 P. Koch, Francisco del Valle, Wolfgang E. Berdel, Journal of Clinical Oncology	2001	487
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia Klaus H. Metzeler, Manuela Hummel, Clara D. Bloomfield, Blood	2008	445
Long-Term Prognosis of Individuals With Right Precordial ST-Segment–Elevation Brugada Syndrome Lars Eckardt, Vincent Probst, J SMITS, Circulation	2005	444
Lipoprotein (a) and Genetic Polymorphisms of Clotting Factor V, Prothrombin, and Methylenetetrahydrofolate Reductase Are Risk Factors of Spontaneous Ischemic Stroke in Childhood Ulrike Nowak‐Göttl, Ronald Sträter, Achim Heinecke, Blood	1999	347
Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer Michael Thomas, Christian Rübe, Petra Hoffknecht, The Lancet Oncology Preoperative ChemotherapyMedicineRandomised TrialPreoperative ChemoradiationBronchial Neoplasm	2008	340
Prospective assessment of risk factors for recurrent stroke during childhood-a 5-year follow-up study Ronald Sträter, Sabine Becker, Arnold von Eckardstein, The Lancet Ischemic StrokePediatric EpidemiologyCardiovascular DiseaseAtherosclerosisMedicine	2002	338
Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group Thomas Büchner, Wolfgang E. Berdel, Claudia Haferlach, Journal of Clinical Oncology	2008	337
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group. Thomas Büchner, Wolfgang Hiddemann, Bernhard Wörmann, PubMed	1999	321
Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial Hubert Serve, Utz Krug, Ruth Wagner, Journal of Clinical Oncology	2013	309
Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes Utz Krug, Christoph Röllig, Anja Koschmieder, The Lancet Hematological MalignancyPrognostic EvaluationMedicineMixed-phenotype Acute LeukemiaPrognosis	2010	302

Page 1